RAD51C NM_058216.3(RAD51C):c.93del (p.Phe32fs)

CI-VAR-00026854Explore in graph →p.Phe32fsNM_058216.3:c.93delClinVar 182847 rs730881942

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
182847	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	2	Breast-ovarian cancer, familial, susceptibility to, 3; Hereditary cancer-predisposing syndrome; Fanconi anemia complementation group O; Hereditary breast ovarian cancer syndrome; Ovarian neoplasm; Inherited ovarian cancer (without breast cancer); RAD51C-related cancer predisposition; RAD51C-related disorder	germline	21	Feb 10, 2026	clinvar